Certified by Founder
Lodge
Nomic Bio
start up
Canada
- Montreal, QC
- 18/09/2024
- Series B
- $42,000,000
Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. The nELISA was designed to seamlessly integrate into current workflows in biology and is uniquely adaptable to a wide variety of use cases within drug and biomarker development workflows. Nomic is headquartered in Montreal, with labs and offices in Boston. For more information, visit www.nomic.bio.
- Industry Biotechnology Research
- Website https://nomic.bio/
- LinkedIn https://www.linkedin.com/company/nomicbio/
Cosmico | $12,000,000 | (May 19, 2026)
Hacktron AI | $2,900,000 | (May 19, 2026)
Shyld AI | $13,400,000 | (May 19, 2026)
Onramp (1) | $12,500,000 | (May 19, 2026)
Sprouts.ai | $9,000,000 | (May 19, 2026)
Transient.AI | Undisclosed Amount | (May 19, 2026)
Furientis | $5,000,000 | (May 19, 2026)
Cimento AI | $3,000,000 | (May 19, 2026)
Multiverse | $70,000,000 | (May 19, 2026)
Blink - Employee Experience Platform | $17,000,000 | (May 19, 2026)
Elliptic | $120,000,000 | (May 19, 2026)
Arkeus | $18,000,000 | (May 19, 2026)
Greenpixie | $6,305,755 | (May 19, 2026)